Form D — Athos Therapeutics, Inc.
0001885079-26-000001 · filed May 15, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- Rule 506(b)
- Reported offering amount
- $20,000,000
- Reported amount sold
- $10,282,887
- Minimum investment
- $0
- Investors
- 40
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Athos Therapeutics, Inc.
- CIK
- 1885079
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 1123 W. CARSON ST.
TORRANCE, California 90502 - Phone
- 857-222-0410
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Dimitrios Iliopoulos · Executive OfficerTORRANCE, California Find on LinkedIn ↗
-
Allan J. Pantuck · Executive OfficerTORRANCE, California Find on LinkedIn ↗
-
Carl McKinzie · DirectorTORRANCE, California Find on LinkedIn ↗
-
Joel Cohen · DirectorTORRANCE, California Find on LinkedIn ↗
-
Anthony Zingale · DirectorTORRANCE, California Find on LinkedIn ↗
-
Laurence Stein · DirectorTorrance, California Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗